Ultragenyx Pharma (RARE) & Kyowa Kirin Announce Launch of Crysvita (burosumab-twza) in U.S.
Tweet Send to a Friend
Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) and Kyowa Hakko Kirin Co. Ltd, (Kyowa Hakko Kirin), and Kyowa Kirin International PLC (Kyowa ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
